Citation Impact
Citing Papers
Resveratrol Inhibits Myeloma Cell Growth, Prevents Osteoclast Formation, and Promotes Osteoblast Differentiation
2005
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
The Systemic Amyloidoses
1997 Standout
The role of P-glycoprotein in drug resistance in multiple myeloma
2014
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
2015 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Signaling Properties of Hyaluronan Receptors
2002
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A
2005
Cancer Statistics, 2006
2006 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Hyaluronan and Homeostasis: A Balancing Act
2002
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Putting tumours in context
2001 Standout
Cytokine Expression in Multiple Myeloma and Monoclonal Gammopathy: Analysis by Reverse Transcription/Polymerase Chain Reaction and Quantitative PCR
1996
Targeting multidrug resistance in cancer
2006 Standout
Extracellular matrix structure
2015 Standout
CSF-1 Receptor Signaling in Myeloid Cells
2014
EMX2 Gene Expression in the Female Reproductive Tract and Aberrant Expression in the Endometrium of Patients with Endometriosis
2004 Standout
Roadmap to embryo implantation: clues from mouse models
2006 Standout
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
Differences in Hyaluronic Acid-mediated Functions and Signaling in Arterial, Microvessel, and Vein-derived Human Endothelial Cells
2000
INTERACTION OF TUMOR AND HOST CELLS WITH ADHESION AND EXTRACELLULAR MATRIX MOLECULES IN THE DEVELOPMENT OF MULTIPLE MYELOMA
1997
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Mechanisms of Bone Metastasis
2004 Standout
The Biology of CSF-1 and Its Receptor
1992
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo
2000
Hyaluronate Receptors Mediating Glioma Cell Migration and Proliferation
2001
Molecular Mechanisms of Amyloidosis
2003 Standout
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)
2001
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Cytokine Network in Human Multiple Myeloma
1992
HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.
1998
Tumour stem cells and drug resistance
2005 Standout
Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients
2002
Mechanisms of Bone Lesions in Multiple Myeloma
1992
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
2006 StandoutNobel
Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys
2005
The Antisense Approach in Amyloid Light Chain Amyloidosis: Identification of Monoclonal Ig and Inhibition of Its Production by Antisense Oligonucleotides in In Vitro and In Vivo Models
2002
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
2007 StandoutScience
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins
2000
Potential Role for Hyaluronan and the Hyaluronan Receptor RHAMM in Mobilization and Trafficking of Hematopoietic Progenitor Cells
1999
Biodegradable polymers as biomaterials
2007 Standout
Overexpression of the Receptor for Hyaluronan-Mediated Motility (RHAMM) Characterizes the Malignant Clone in Multiple Myeloma: Identification of Three Distinct RHAMM Variants
1999
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
1998
RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability
2003
Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma
1996
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.
1998
Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia
2000
Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance
2008
Primary Myeloma Cells Growing in SCID-hu Mice: A Model for Studying the Biology and Treatment of Myeloma and Its Manifestations
1998
Works of AR Belch being referenced
Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers
1998
Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies
1991
In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365]
1995
Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44
1996
Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies
1991
Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma
1994
Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma
1994